Endothelial dysfunction in Buerger's disease and its relation to markers of inflammation

European Journal of Clinical Investigation

Volumn 36, Issue 6, 2006, Pages 376-382

  Joras, M ^a   Poredos P ^a   Fras, Z ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Buerger's disease; Endothelium dependent vasodilation (flow mediated vasodilation); Endothelium independent vasodilation; Inflammation; Intima media thickness

Indexed keywords

ALPHA 2 GLOBULIN; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; ARTERY DILATATION; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ARTICLE; BRACHIAL ARTERY; BUERGER DISEASE; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; FIBRINOLYSIS; HUMAN; INFLAMMATION; MALE; PATHOGENESIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REMISSION; SEDIMENTATION RATE;

ADULT; BIOLOGICAL MARKERS; BLOOD COAGULATION; BRACHIAL ARTERY; CAROTID ARTERY, COMMON; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOLYSIS; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; THROMBOANGIITIS OBLITERANS; TUNICA INTIMA; TUNICA MEDIA; VASODILATION;

EID: 33646674046     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2006.01646.x     Document Type: Article

References (34)

1. Olin JW. Thromboangiitis obliterans (Buerger"s disease). N Engl J Med 2000 343 : 864 9.
2. Olin JW, Young JR, Graor RA, Ruschhaupt WF, Bartholomew JR. The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease). Circulation 1990 82 Suppl IV IV 3 -IV 8.
3. Szuba A, Cooke JP. Thromboangiitis obliterans - an update on Buerger's disease. West J Med 1998 168 : 255 60.
4. Mishima Y. Thromboangiitis obliterans (Buerger's disease). Int J Cardiol 1996 54 Suppl S185 7.
5. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994 24 : 1468 74.
6. Healy B. Endothelial cell dysfunction: an emerging endocrinopathy linked to coronary disease. J Am Coll Cardiol 1990 16 : 357 8.
7. Poredoš P. Endothelial dysfunction in the pathogenesis of atherosclerosis. Clin Appl Thromb Haemost 2001 7 : 276 80
8. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991 134 : 250 6.
9. Grobbee DE, Bots ML. Carotid artery intima-media thickness as an indicator of generalized atherosclerosis. J Intern Med 1994 236 : 567 73.
10. Makita S, Nakamura M, Murakami H, Komoda K, Kawazoe K, Hiramori K. Impaired endothelium-dependent vasorelaxation in peripheral vasculature of patients with thromboangiitis obliterans (Buerger's disease). Circulation 1996 94 Suppl II II211 5.
11. Choudhury NA, Pietraszek MH, Hachiya T, Baba S, Sakaguchi S, Takada Y et al. Plasminogen activators and plasminogen activator inhibitor 1 before and after venous occlusion of the upper limb in thromboangiitis obliterans (Buerger's disease). Thromb Res 1992 66 : 321 9.
12. Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu KK. Association of fibrinolytic parameters with early atherosclerosis. Circulation 1995 91 : 284 90.
13. Shionoya S. Diagnostic criteria of Buerger's disease. Int J Cardiol 1998 66 Suppl 1 S243 5.
14. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992 340 : 1111 5.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 18 : 499 502.
16. Rånby M, Bergsdorf N, Nilsson T, Mellbring G, Winblad B, Bucht G. Age dependence of tissue plasminogen activator concentration in plasma, as studied by an improved enzyme-linked immunosorbent assay. Clin Chem 1986 32 : 2160 5.
17. Declerck PJ, Alessi MC, Verstreken M, Kruitkof EKO, Juhan-Vague I, Collen D. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 1988 71 : 220 5.
18. Wahlander K, Tengborn L, Hellstrom M, Olmarker AH, Peterson LE, Stigendal L et al. Comparison of various d-dimer tests for the diagnosis of deep venous thrombosis. Blood Coagul Fibrinolysis 1999 10 : 121 6.
19. Rånby M, Norrman B, Wallen P. A sensitive assay for tissue plasminogen activator. Thromb Res 1982 27 : 743 9.
20. Verheijen JH, Mullaart E, Chang GTG, Kluft C, Wijngaards G. A simple and sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemost 1982 48 : 266 9.
21. Eriksson P, Rånby M, Gyzander E, Risberg B. Determination of plasminogen activator inhibitor in plasma using t-PA and chromogenic single-point poly-D-lysine stimulated assay. Thromb Res 1988 50 : 91 101.
22. Chmielewska J, Rånby M, Wiman B. Evidence of rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 1983 31 : 427 36.
23. Clauss A. Gerinnungsphysiologische Schnellmetode zur Bestimmung des Fibrinogens. Acta Haemat 1957 17 : 237 46.
24. Brevetti G, Martone VD, de Cristofaro T, Corrado S, Silvestro A, DiDonato AM. et al. High levels of adhesion molecules are associated with impaired endothelium-dependent vasodilation in patients with peripheral arterial disease. Thromb Haemost 2001 85 : 63 6.
25. Price DT, Loscalzo J. Cellular adhesion molecules and atherogenesis. Am J Med 1999 107 : 85 97.
26. Malik I, Danesh J, Whincup P, Bhatia V, Papacosta O, Walker M et al. Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet 2001 358 : 971 5.
27. Sari RA, Kiziltunc A, Taysy S, Akdemyr S, Gundogdu M. Levels of soluble E-selectin in patients with active Behcet's disease. Clin Rheumatol 2005 24 : 55 9.
28. Cohen Tervaert JW, Kallenberg CGM. Cell adhesion molecules in vasculitis. Curr Opin Rheumatol 1997 9 : 16 25.
29. Ara J, Mirapeix E, Arrizabalaga P, Rodriguez R, Ascaso C, Abellana R et al. Circulating soluble adhesion molecules in ANCA-associated vasculitis. Nephrol Dial Transplant 2001 16 : 276 85.
30. Kevil CG, Bullard DC. Roles of leukocyte/endothelial cell adhesion molecules in the pathogenesis of vasculitis. Am J Med 1999 106 : 677 87.
31. Vanhee D, Delneste Y, Lassalle P, Gosset P, Joseph M, Tonnel AB. Modulation of endothelial cell adhesion molecule expression in a situation of chronic inflammatory stimulation. Cell Immunol 1994 155 : 446 56.
32. Lambert J, Aarsen M, Donker AJM, Stehouwer CDA. Endothelium-dependent and - independent vasodilation of large arteries in normoalbuminuric insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996 16 : 705 11.
33. Brands MW, Fitzgerald SM. Acute endothelium-mediated vasodilation is not impaired at the onset of diabetes. Hypertension 1998 32 : 541 7.
34. Stary HC. Changes in components and structure of atherosclerotic lesions developing from childhood to middle age in coronary arteries. Basic Res Cardiol 1994 89 Suppl 1 17 32.